FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2588520105> ?p ?o ?g. }

• W2588520105 endingPage "e0172140" @default.
• W2588520105 startingPage "e0172140" @default.
• W2588520105 abstract "The formation of acquired drug resistance is a major reason for the failure of anti-cancer therapies after initial response. Here, we introduce a novel model of acquired oxaliplatin resistance, a sub-line of the non-MYCN-amplified neuroblastoma cell line SK-N-AS that was adapted to growth in the presence of 4000 ng/mL oxaliplatin (SK-N-ASrOXALI4000). SK-N-ASrOXALI4000 cells displayed enhanced chromosomal aberrations compared to SK-N-AS, as indicated by 24-chromosome fluorescence in situ hybridisation. Moreover, SK-N-ASrOXALI4000 cells were resistant not only to oxaliplatin but also to the two other commonly used anti-cancer platinum agents cisplatin and carboplatin. SK-N-ASrOXALI4000 cells exhibited a stable resistance phenotype that was not affected by culturing the cells for 10 weeks in the absence of oxaliplatin. Interestingly, SK-N-ASrOXALI4000 cells showed no cross resistance to gemcitabine and increased sensitivity to doxorubicin and UVC radiation, alternative treatments that like platinum drugs target DNA integrity. Notably, UVC-induced DNA damage is thought to be predominantly repaired by nucleotide excision repair and nucleotide excision repair has been described as the main oxaliplatin-induced DNA damage repair system. SK-N-ASrOXALI4000 cells were also more sensitive to lysis by influenza A virus, a candidate for oncolytic therapy, than SK-N-AS cells. In conclusion, we introduce a novel oxaliplatin resistance model. The oxaliplatin resistance mechanisms in SK-N-ASrOXALI4000 cells appear to be complex and not to directly depend on enhanced DNA repair capacity. Models of oxaliplatin resistance are of particular relevance since research on platinum drugs has so far predominantly focused on cisplatin and carboplatin." @default.
• W2588520105 created "2017-02-24" @default.
• W2588520105 creator A5006454149 @default.
• W2588520105 creator A5007033865 @default.
• W2588520105 creator A5008672438 @default.
• W2588520105 creator A5014094726 @default.
• W2588520105 creator A5014630772 @default.
• W2588520105 creator A5014923996 @default.
• W2588520105 creator A5015193618 @default.
• W2588520105 creator A5017406022 @default.
• W2588520105 creator A5017604259 @default.
• W2588520105 creator A5019565440 @default.
• W2588520105 creator A5022093166 @default.
• W2588520105 creator A5022482908 @default.
• W2588520105 creator A5022558805 @default.
• W2588520105 creator A5027709558 @default.
• W2588520105 creator A5032870496 @default.
• W2588520105 creator A5036679401 @default.
• W2588520105 creator A5038344083 @default.
• W2588520105 creator A5044630886 @default.
• W2588520105 creator A5046823754 @default.
• W2588520105 creator A5047480351 @default.
• W2588520105 creator A5047493620 @default.
• W2588520105 creator A5052138156 @default.
• W2588520105 creator A5054810742 @default.
• W2588520105 creator A5055711992 @default.
• W2588520105 creator A5057009118 @default.
• W2588520105 creator A5058177040 @default.
• W2588520105 creator A5061735594 @default.
• W2588520105 creator A5064834508 @default.
• W2588520105 creator A5066470348 @default.
• W2588520105 creator A5067741256 @default.
• W2588520105 creator A5074740364 @default.
• W2588520105 creator A5074926676 @default.
• W2588520105 creator A5074965247 @default.
• W2588520105 creator A5075513058 @default.
• W2588520105 creator A5075951811 @default.
• W2588520105 creator A5076496913 @default.
• W2588520105 creator A5082664431 @default.
• W2588520105 creator A5086734169 @default.
• W2588520105 creator A5089484536 @default.
• W2588520105 creator A5090439131 @default.
• W2588520105 date "2017-02-13" @default.
• W2588520105 modified "2023-10-13" @default.
• W2588520105 title "Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS" @default.
• W2588520105 cites W1508781039 @default.
• W2588520105 cites W1543790510 @default.
• W2588520105 cites W1546483925 @default.
• W2588520105 cites W1866746139 @default.
• W2588520105 cites W1969391810 @default.
• W2588520105 cites W1979706457 @default.
• W2588520105 cites W1981088292 @default.
• W2588520105 cites W1985928174 @default.
• W2588520105 cites W1989788129 @default.
• W2588520105 cites W2007012961 @default.
• W2588520105 cites W2012687605 @default.
• W2588520105 cites W2012994430 @default.
• W2588520105 cites W2020579083 @default.
• W2588520105 cites W2026548544 @default.
• W2588520105 cites W2026743476 @default.
• W2588520105 cites W2032553799 @default.
• W2588520105 cites W2035447242 @default.
• W2588520105 cites W2036223578 @default.
• W2588520105 cites W2040094001 @default.
• W2588520105 cites W2042619042 @default.
• W2588520105 cites W2045246542 @default.
• W2588520105 cites W2051865150 @default.
• W2588520105 cites W2064013031 @default.
• W2588520105 cites W2067931206 @default.
• W2588520105 cites W2068577449 @default.
• W2588520105 cites W2076925241 @default.
• W2588520105 cites W2088536552 @default.
• W2588520105 cites W2092016628 @default.
• W2588520105 cites W2093921289 @default.
• W2588520105 cites W2094694074 @default.
• W2588520105 cites W2104399957 @default.
• W2588520105 cites W2106391833 @default.
• W2588520105 cites W2107438172 @default.
• W2588520105 cites W2108035852 @default.
• W2588520105 cites W2108512354 @default.
• W2588520105 cites W2117582069 @default.
• W2588520105 cites W2119578383 @default.
• W2588520105 cites W2121846636 @default.
• W2588520105 cites W2126680178 @default.
• W2588520105 cites W2127812467 @default.
• W2588520105 cites W2129586435 @default.
• W2588520105 cites W2130189600 @default.
• W2588520105 cites W2130925781 @default.
• W2588520105 cites W2132865716 @default.
• W2588520105 cites W2141037581 @default.
• W2588520105 cites W2147545245 @default.
• W2588520105 cites W2152785619 @default.
• W2588520105 cites W2153148142 @default.
• W2588520105 cites W2154563079 @default.
• W2588520105 cites W2170780843 @default.
• W2588520105 cites W2170914411 @default.
• W2588520105 cites W2177500163 @default.
• W2588520105 cites W2224415831 @default.

• next